Calgary, Alberta – May 12, 2025 – Willow Biosciences Inc. (“Willow” or the “Company“) (TSX: WLLW) (OTCQB: CANSF), announces its unaudited consolidated
Calgary, Alberta – May 8, 2025 –Willow Biosciences Inc. (the “Company”) (TSX: WLLW) (OTCQB: CANSF) is pleased to announce that
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS
Calgary, Alberta – April 30, 2025 – Willow Biosciences Inc. (the “Company“) (TSX: WLLW) (OTCQB: CANSF) announces the completion today of
Sunnyvale, California – April 25, 2025 – Willow Biosciences Inc.(“Willow” or the “Company“) (TSX: WLLW; OTCQB: CANSF) is pleased to announce
Sunnyvale, California – March 24, 2025 – Willow Biosciences Inc.(“Willow” or the “Company”) (TSX: WLLW; OTCQB: CANSF), a biotechnology company focused
Phone: +1 403 910 5140
Email: info@willowbio.com
© 2023 Willow Biosciences Inc.
Powered by BragDeal Inc.
Focused on identifying and deploying additional genetic elements and solutions to further enhance production of our yeast strains and processes. This state-of-the-art R&D facility includes high-throughput molecular biology and screening technologies, high-end analytical instrumentation and fermentation capabilities along with systems to rapidly evaluate high volumes of data and results.